NNZ-2566: Phase II data

Top-line data from a double-blind, placebo-controlled, U.S. Phase II trial in 53 female Rett syndrome patients ages 16-45 showed that

Read the full 205 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE